Regarding the AML/BA-2 patient, the progression from de novo AML (b, without BCR::ABL1, red circle) to relapse (b, with BCR::ABL1, black circle) occurred without any significant changes in the gene expression profile. The gene discussed is ABL1; the disease is acute myeloid leukemia.